Facilitated endogenous repair: making tissue engineering simple, practical, and economical.

Area of Science:

• Regenerative Medicine
• Tissue Engineering
• Molecular Biology

Background:

• Traditional tissue engineering often requires ex vivo cell culture and manufactured scaffolds.
• Clinical procedures can be invasive and complex.
• Minimizing invasiveness and complexity is crucial for broader clinical application.

Purpose of the Study:

• To introduce facilitated endogenous repair as a novel tissue engineering strategy.
• To harness the body's intrinsic regenerative potential for in situ repair.
• To develop cost-effective, safe, and clinically rapid tissue regeneration methods.

Main Methods:

• Utilizing molecular stimuli, such as gene transfer, to trigger endogenous repair processes.
• Employing direct percutaneous injection of therapeutic vectors (e.g., osteogenic vectors for bone healing).
• Supplementing with autologous progenitor cells and space-filling scaffolds harvested via expedited intraoperative procedures when necessary.

Main Results:

• Demonstrated successful repair of experimental osseous and osteochondral lesions in animal models.
• Showcased the potential for in situ regeneration without extensive ex vivo manipulation.
• Highlighted the feasibility of using minimally invasive techniques for cell and scaffold delivery.

Conclusions:

• Facilitated endogenous repair offers a promising alternative to conventional tissue engineering.
• The strategy is effective, inexpensive, safe, and clinically expeditious.
• The technology has broad applicability for various tissue regeneration needs, particularly in orthopaedics.